Back to companies

Mitsubishi Tanabe Pharma Corp: Patents

View up-to-date information on Mitsubishi Tanabe Pharma Corp patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
AU2018391882A2 Application Compositions and methods for treating or preventing vasomotor symptoms A61K31/472; A61K31/47; A61K45/06; A61P15/12 June 23, 2022
EP3868288A4 Search Report ELEKTROENZEPHALOGRAMMANALYSEGERÄT, ELEKTROENZEPHALOGRAMMANALYSESYSTEM UND ELEKTROENZEPHALOGRAMMANALYSEPROGRAMM A61B2560/02; A61B5/16; A61B5/369; A61B5/374; A61B5/377; A61B5/383; A61B5/4809; A61B5/4824; A61B5/7203 June 22, 2022
WO2022122773A1 Application 4-(2-FLUORO-4-METHOXY-5-3-(((1-METHYLCYCLOBUTYL)METHYL)CARBAMOYL)BICYCLO[2.2.1]HEPTAN-2-YL)CARBAMOYL)PHENOXY)-1-METHYLCYCLOHEXANE-1-CARBOXYLIC ACID DERIVATIVES AND SIMILAR COMPOUNDS AS RXFP1 MODULATORS FOR THE TREATMENT OF HEART FAILURE A61P13/12; A61P9/04; C07B2200/07; C07C237/24; C07C255/57; C07C2601/04; C07C2601/14; C07C2602/38; C07C2602/42; C07D213/79; C07D231/12; C07D231/14; C07D237/20; C07D239/42; C07D241/12; C07D263/40; C07D275/02; C07D307/24; C07D333/38; C07D487/04; C07D493/08 June 16, 2022
EP3851121A4 Search Report PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT MENSCHLICHEN MONOKLONALEN ANTI-IL-33-ANTIKÖRPERN A61K47/02; A61K47/10; A61K47/183; A61K47/22; A61K47/26; A61K9/0019; A61K9/19; A61P11/06; A61P15/00; A61P17/00; A61P37/08; C07K16/244; C07K2317/56; C07K2317/565; C07K2317/94 June 08, 2022
EP3819285B1 Grant 4-ALKOXY-3-(TRIFLUORMETHYL)BENZYL-ALKOHOL-HERSTELLUNGSVERFAHREN C07C41/26; C07C213/08; C07F9/4056; C07C43/23; C07C217/64; C07C213/02 June 08, 2022
Discover Company Analytics for more exclusive patent trend analysis Discover Company Analytics for more exclusive patent trend analysis Get Started

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you subscribe Identify the top inventors associated with your target company when you subscribe Learn More
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer